par Botte, Louis;Gilles, Christian ;Evrard, Jean-Luc;Mesters, Patrick;Wolfrum, C.;Berger, Mathias;Hellstern, K.;Ward, John
Référence Acta psychiatrica Scandinavica. Supplementum, 82, 360, page (42)
Publication Publié, 1990
Référence Acta psychiatrica Scandinavica. Supplementum, 82, 360, page (42)
Publication Publié, 1990
Article révisé par les pairs
Résumé : | Moclobemide was compared with placebo for antidepressant activity, tolerance and safety in 2 parallel groups of 23 and 24 depressed patients. At the end of treatment (4 weeks or longer), 9 patients on moclobemide (41%) showed an improvement ≥50% on the Hamilton Rating Scale for Depression, compared with only 4 (17%) of those on placebo. The overall assessment of efficacy was significantly better for moclobemide (good or very good results in 50% of patients) than for placebo (80% poor results). Moclobemide was well or very well tolerated by 85% of patients and placebo by 100%. Moclobemide was thus shown to be clearly more effective than placebo and only slightly less well tolerated. |